Key Events This Week
29 Dec: Sharp gap down and intraday low at Rs.74.11 (-9.74%)
30 Dec - 2 Jan: Stock price remained static at Rs.74.11 despite Sensex gains
2 Jan: Week closes at Rs.74.11, down 9.74% for the week
Feb 13
BSE+NSE Vol: 500
The next results date for Sarda Proteins Ltd is scheduled for 14 February 2026....
Read full news article
29 Dec: Sharp gap down and intraday low at Rs.74.11 (-9.74%)
30 Dec - 2 Jan: Stock price remained static at Rs.74.11 despite Sensex gains
2 Jan: Week closes at Rs.74.11, down 9.74% for the week

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Sarda Proteins experienced a significant intraday decline, touching a low of Rs 74.11, reflecting a price pressure of 9.74% during today’s trading session. The stock’s performance contrasted sharply with broader market trends, highlighting immediate pressures within the edible oil sector.
Read full news article
Sarda Proteins witnessed a significant gap down at the opening of trading today, with the stock price declining by 9.74% to open at Rs 74.11. This sharp drop reflects heightened market concerns within the edible oil sector, as the stock underperformed both its sector peers and the broader Sensex index.
Read full news article
Sarda Proteins has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. This adjustment highlights the evolving challenges faced by the edible oil company, particularly in its financial performance and valuation metrics.
Read full news article
Sarda Proteins Ltd has encountered significant selling pressure today, with the stock registering a sharp decline of 4.58% and exhibiting a complete absence of buyers. This distress selling comes amid a series of consecutive losses, signalling heightened market caution towards the edible oil company.
Read full news article
Sarda Proteins has captured market attention with an unusual trading pattern characterised by an upper circuit lock and exclusively buy orders in the queue. This rare phenomenon highlights intense demand for the stock, with no sellers willing to part with shares, signalling a potential multi-day circuit scenario that investors are closely monitoring.
Read full news article
Sarda Proteins Ltd is currently experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading floor. The edible oil company’s shares have recorded consecutive declines, reflecting distress selling signals that have intensified over recent months.
Read full news articleSarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended on 31st December 2025
Intimation of Trading Window Closure
Outcome of Board Meeting held on 08-12-2025
14 Feb 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available